← The SEC Ephemeris: the whole map
SYDNEXIS Inc. atropine sulfate
In the graph: all 1 documents (4 pages).
- Application
- NDA 219694
- Ticker
- SYDNEXIS Inc.
- Product
- atropine sulfate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- October 22, 2025
From FDA letters and SEC filings. Not investment or medical advice.